Please try another search
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Jason Ryan | 49 | 2021 | Independent Director |
Andrew Spaventa | 38 | 2016 | Founder, CEO, President & Chairperson of the Board |
Lawrence Fong | - | 2022 | Member of Scientific Advisory Board |
Elaine R. Mardis | 60 | 2022 | Member of Scientific Advisory Board & Independent Director |
David H. Ledbetter | - | 2022 | Member of Scientific Advisory Board |
Daniel D. Shoemaker | 55 | 2022 | Member of Scientific Advisory Board |
Kim Puloma Kamdar | 56 | 2017 | Independent Director |
Eli N. Glezer | 55 | 2016 | Founder, Chief Scientific Officer & Chair of Scientific Advisory Board |
David L. Barker | 82 | 2016 | Founder, Member of Scientific Advisory Board & Independent Director |
Marcia T. Eisenberg | 64 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review